Company / Working Capital
Masimo Working Capital History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$554.4M
FY2025
5-year range
$554.4M / $970.8M
FY2021-FY2025
Trend
-8.8%
vs FY2024
Sector context
#55 of 160
Health Care
What the data says
At $554M, Masimo's working capital ranks #55 of 160 in the Health Care sector. Working Capital has declined for 4 consecutive years, from $971M in FY2021 to $554M in FY2025.
Based on SEC 10-K filings.
$554M in FY2025 with a 5-year CAGR of -8.6%.
Declined from $668M to $554M over the past 2 years.
Health Care sector context is included.
Working Capital over time
Growth rates
- 3-Year CAGR
- -6.5%
- 5-Year CAGR
- -8.6%
- 10-Year CAGR
- -
Sector benchmark
#55 of 160 in Health CareTop 34% of 160This company $554.4M Sector average $757.1M
▼
-26.8% below sector average
Key checks
Key Insights
- Masimo's working capital has declined for 4 consecutive years.
- 5-year CAGR of -8.6%, indicating a declining trend.
- In FY2025, working capital decreased 8.8% year-over-year.
- Ranks #55 out of 160 companies in the Health Care sector.
Company context
Key Data Points
- Negative profit margin: -14.6%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $554.4M | -8.8% |
| FY2024 | $608.1M | -9.0% |
| FY2023 | $668.1M | -1.5% |
| FY2022 | $678.6M | -30.1% |
| FY2021 | $970.8M | +11.9% |
| FY2020 | $867.3M | +5.3% |
| FY2019 | $823.8M | +29.2% |
| FY2018 | $637.5M | +48.2% |
| FY2017 | $430.0M | +49.9% |
| FY2016 | $286.9M | +72.3% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026